Expansion in Life Sciences Pace's recent investment in two new life sciences laboratories and its expanded CDMO/CRO services present opportunities to offer specialized biopharmaceutical and pharmaceutical testing solutions, particularly for clients seeking advanced R&D and manufacturing support.

Innovative Testing Capabilities The company's launch of ultrashort-chain PFAS testing and recognition through an environmental award highlight its cutting-edge analytical services, creating prospects for clients needing advanced environmental testing and regulatory compliance.

Strategic Industry Partnerships Partnership with Aspirebiolabs for drug development and stability studies indicates a collaborative approach within the biotech and pharmaceutical sectors, opening doors for complementary testing, formulation, and stability solutions.

Sustainability Focus Pace's recent addition of respirable crystalline silica testing and commitment to environmental safety signals an emphasis on environmental health monitoring, ideal for companies with needs in industrial safety, environmental compliance, and sustainable practices.

Market Leadership & Growth With revenue in the billion-dollar range and recent leadership appointments, Pace is positioned as a major player in environmental and life sciences sectors, making them a strategic partner for companies aiming to enhance compliance, innovation, and market competitiveness.